Drug Profile
Anti-CD3 immunotoxin
Alternative Names: Anti-CD3 ITLatest Information Update: 06 Sep 2006
Price :
$50
*
At a glance
- Originator National Institute of Mental Health
- Class Drug conjugates; Immunotoxins
- Mechanism of Action Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Transplant rejection